Author Correction: High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade.

More about this publication

Nature medicine
  • Publication date 05-02-2021

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.